Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448
Status:
Completed
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
Clinical trial is to evaluate the effect of ethnicity and food on the pharmacokinetics (how a
drug is absorbed, metabolized, distributed and excreted; plasma drug concentration will be
measured in this clinical trial) of YH25448, which Yuhan Corporation plans to develop as a
therapeutic agent for Non-Small Cell Lung Cancer.